GLPG Galapagos N.V.
Healthcare$27.64+0.55%ClosedMarket Cap: $1.82B
As of 2026-05-26
Valuation
P/E (TTM)
5.83
PEG
0.02
P/B
0.49
P/S
1.52
EV/EBITDA
4.63
DCF Value
$-24.08
FCF Yield
-19.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
98.0%
Operating Margin
36.4%
Net Margin
46.8%
ROE
16.9%
ROA
14.5%
ROIC
11.6%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $6.5M | 26.0% | $-63.7M | $14.5M | $— | — |
| Q4 null | $900.8M | 99.9% | $758.8M | $782.1M | $— | — |
| FY null | $1.11B | 97.3% | $501.4M | $320.9M | $— | — |
| Q3 null | $71.2M | 84.8% | $-246.4M | $-202.1M | $— | — |
| Q2 null | $65.3M | 92.8% | $-57.0M | $-105.7M | $— | — |
| Q1 null | $75.0M | 81.7% | $-158.7M | $-153.4M | $— | — |
| Q4 null | $75.5M | -49.6% | $-62.7M | $25.3M | $— | — |
| FY null | $275.6M | 87.4% | $-188.3M | $74.1M | $— | — |
| Q3 null | $59.8M | 100.0% | $-54.3M | $-50.4M | $— | — |
| Q2 null | $77.9M | 78.7% | $-38.2M | $9.0M | $— | — |
| Q1 null | $62.4M | 95.9% | $-33.1M | $90.2M | $— | — |
| Q4 2023 | $-209.1M | 100.0% | $-69.3M | $157.6M | $-0.88 | — |